Summary
Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The South Korean pharmaceuticals market had total revenues of $19.5m in 2018, representing a compound annual growth rate (CAGR) of 1.5% between 2014 and 2018.
- The performance of the market is forecast to accelerate, with an anticipated CAGR of 4.8% for the five-year period 2018-2023, which is expected to drive the market to a value of $24.7m by the end of 2023.
- An aging population and strong economic fundamentals are incentivising the robust growth of South Korea’s pharmaceutical sector.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Korea
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Korea
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Korea pharmaceuticals market with five year forecasts
Reasons to buy
- What was the size of the South Korea pharmaceuticals market by value in 2018?
- What will be the size of the South Korea pharmaceuticals market in 2023?
- What factors are affecting the strength of competition in the South Korea pharmaceuticals market?
- How has the market performed over the last five years?
- How large is South Korea’s pharmaceuticals market in relation to its regional counterparts?
'
Table of Contents
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
CKD Corp
Daewoong Pharmaceutical Co Ltd
Beijing Hanmi Pharmaceutical Co Ltd
Pfizer Inc
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: South Korea pharmaceuticals market value: $ billion, 2014-18
Table 2: South Korea pharmaceuticals market geography segmentation: $ billion, 2018
Table 3: South Korea pharmaceuticals market share: % share, by value, 2018
Table 4: South Korea pharmaceuticals market value forecast: $ billion, 2018-23
Table 5: CKD Corp: key facts
Table 6: CKD Corp: key financials ($)
Table 7: CKD Corp: key financials (KRW)
Table 8: CKD Corp: key financial ratios
Table 9: Daewoong Pharmaceutical Co Ltd: key facts
Table 10: Daewoong Pharmaceutical Co Ltd: key financials ($)
Table 11: Daewoong Pharmaceutical Co Ltd: key financials (KRW)
Table 12: Daewoong Pharmaceutical Co Ltd: key financial ratios
Table 13: Beijing Hanmi Pharmaceutical Co Ltd: key facts
Table 14: Beijing Hanmi Pharmaceutical Co Ltd: key financials ($)
Table 15: Beijing Hanmi Pharmaceutical Co Ltd: key financials (KRW)
Table 16: Beijing Hanmi Pharmaceutical Co Ltd: key financial ratios
Table 17: Pfizer Inc: key facts
Table 18: Pfizer Inc: key financials ($)
Table 19: Pfizer Inc: key financial ratios
Table 20: South Korea size of population (million), 2014-18
Table 21: South Korea gdp (constant 2005 prices, $ billion), 2014-18
Table 22: South Korea gdp (current prices, $ billion), 2014-18
Table 23: South Korea inflation, 2014-18
Table 24: South Korea consumer price index (absolute), 2014-18
Table 25: South Korea exchange rate, 2014-18
List of Figures
Figure 1: South Korea pharmaceuticals market value: $ billion, 2014-18
Figure 2: South Korea pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 3: South Korea pharmaceuticals market share: % share, by value, 2018
Figure 4: South Korea pharmaceuticals market value forecast: $ billion, 2018-23
Figure 5: Forces driving competition in the pharmaceuticals market in South Korea, 2018
Figure 6: Drivers of buyer power in the pharmaceuticals market in South Korea, 2018
Figure 7: Drivers of supplier power in the pharmaceuticals market in South Korea, 2018
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2018
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2018
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2018
Figure 11: CKD Corp: revenues & profitability
Figure 12: CKD Corp: assets & liabilities
Figure 13: Daewoong Pharmaceutical Co Ltd: revenues & profitability
Figure 14: Daewoong Pharmaceutical Co Ltd: assets & liabilities
Figure 15: Beijing Hanmi Pharmaceutical Co Ltd: revenues & profitability
Figure 16: Beijing Hanmi Pharmaceutical Co Ltd: assets & liabilities
Figure 17: Pfizer Inc: revenues & profitability
Figure 18: Pfizer Inc: assets & liabilities
